Fruit and vegetable intake and liver cancer risk: a meta-analysis of prospective cohort studies
- PMID: 31364650
- DOI: 10.1039/c9fo00804g
Fruit and vegetable intake and liver cancer risk: a meta-analysis of prospective cohort studies
Abstract
The associations of vegetable and fruit intake with liver cancer risk have been inconsistent based on epidemiological studies. The present study aimed to quantitatively evaluate these associations with prospective cohort studies. A systematic literature search was performed with PubMed and Scopus databases up to June 2019. Multivariate-adjusted relative risks (RRs) with a corresponding 95% confidence interval (CI) for the highest versus lowest category were pooled by using a random-effects model. Pre-specified subgroup and univariate meta-regression analyses were performed to identify the sources of heterogeneity. Dose-response analysis was conducted by using the variance weighted least squares regression model. Nine independent prospective cohort studies with 1703 liver cancer events and 1 326 176 participants were included for data synthesis. The summary estimates showed that higher vegetable intake was associated with a 39% (95%CI: 0.50, 0.75) reduction in liver cancer risk, with no significant between-study heterogeneity (P = 0.057). Dose-response analysis indicated that the risk of liver cancer was reduced by 4% (95%CI: 0.97, 0.95; P for trend <0.001) with a 100 gram per day increment of vegetable intake. Subgroup analysis showed that higher intakes of vegetables were associated with a 50% (95%CI: 0.35, 0.72) reduction of liver cancer risk in males, but not in females. However, a non-significant association was found between fruit intake and liver cancer risk. The present study provides strong evidence that higher intakes of vegetables would have beneficial effects on the prevention of liver cancer, especially for males.
Similar articles
-
The Associations of Fruit and Vegetable Intake with Lung Cancer Risk in Participants with Different Smoking Status: A Meta-Analysis of Prospective Cohort Studies.Nutrients. 2019 Aug 2;11(8):1791. doi: 10.3390/nu11081791. Nutrients. 2019. PMID: 31382476 Free PMC article. Review.
-
Fruit and vegetable consumption and risk of depression: accumulative evidence from an updated systematic review and meta-analysis of epidemiological studies.Br J Nutr. 2018 May;119(10):1087-1101. doi: 10.1017/S0007114518000697. Br J Nutr. 2018. PMID: 29759102
-
Dietary intakes of fruits and vegetables and lung cancer risk in participants with different smoking status: a meta-analysis of prospective cohort studies.Asia Pac J Clin Nutr. 2019;28(4):770-782. doi: 10.6133/apjcn.201912_28(4).0014. Asia Pac J Clin Nutr. 2019. PMID: 31826375
-
Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study.Am J Clin Nutr. 2000 Oct;72(4):922-8. doi: 10.1093/ajcn/72.4.922. Am J Clin Nutr. 2000. PMID: 11010932 Clinical Trial.
-
Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.Gastroenterology. 2014 Nov;147(5):1031-42. doi: 10.1053/j.gastro.2014.08.005. Epub 2014 Aug 13. Gastroenterology. 2014. PMID: 25127680 Review.
Cited by
-
Diet and Risk of Non-Alcoholic Fatty Liver Disease, Cirrhosis, and Liver Cancer: A Large Prospective Cohort Study in UK Biobank.Nutrients. 2022 Dec 15;14(24):5335. doi: 10.3390/nu14245335. Nutrients. 2022. PMID: 36558494 Free PMC article.
-
Guided Metabolic Detoxification Program Supports Phase II Detoxification Enzymes and Antioxidant Balance in Healthy Participants.Nutrients. 2023 May 6;15(9):2209. doi: 10.3390/nu15092209. Nutrients. 2023. PMID: 37432335 Free PMC article. Clinical Trial.
-
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations.Cancers (Basel). 2021 Dec 26;14(1):103. doi: 10.3390/cancers14010103. Cancers (Basel). 2021. PMID: 35008267 Free PMC article. Review.
-
Lifestyle factors in hepatocellular carcinoma: From pathogenesis to prognosis.World J Clin Oncol. 2025 Jul 24;16(7):107723. doi: 10.5306/wjco.v16.i7.107723. World J Clin Oncol. 2025. PMID: 40741187 Free PMC article. Review.
-
A convergent synthetic platform for dual anticancer drugs functionalized by reduced graphene nanocomposite delivery for hepatocellular cancer.Drug Deliv. 2021 Dec;28(1):1982-1994. doi: 10.1080/10717544.2021.1974606. Drug Deliv. 2021. Retraction in: Drug Deliv. 2024 Dec;31(1):2368971. doi: 10.1080/10717544.2024.2368971. PMID: 34569406 Free PMC article. Retracted.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical